RNS for the LAYMAN23 Feb 2022 16:12
Ok... it appears a large number of you do not know how to read.
Read the RNS again! Especially paying attention to the MTA paragraphs and Future Prospects paragraphs.
Under MTAs it clearly states "During 2020 we entered into three MTAs..." and goes on to say two of these are now defunct.
In the last para it then goes on to say "As soon as the Company is in a position to publicly disclose material progression or otherwise in respect of MTAs it will do so. In the meantime, it will only announce further MTAs when able to without restrictions of confidentiality or in respect of a defined commercial agreement."
See where I'm going?
Skip to the Future Prospects heading in the RNS... then skip to the fifth paragraph...
"In parallel, we are working with a number of MTA partners assessing how Nuvec® may enhance their proprietary technologies. Whilst we are not there yet and it will be results driven, our path to the commercialisation of Nuvec® is clearer now than perhaps at any time previously."
STILL THINK THEY ONLY HAVE 1x MTA??? Or only 1 they can tell us about for reasons such as NDA... etc etc...